HSE may force drug cost cut in absence of pharma deal

The Health Service Executive may impose drug price cuts in the absence of a deal with pharmaceutical companies.

HSE may force drug cost cut in absence of pharma deal

The HSE is considering its options, including invoking its legislative powers, after the State and the Irish Pharmaceutical Healthcare Association (IPHA) failed to reach an agreement on price reductions.

“It did not prove possible in the negotiations to reach an agreement that would deliver on the State’s objectives,” a Department of Health spokesman said.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited